Aquestive Therapeutics Inc - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
AQST Nasdaq 2834 http://www.monosolrx.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Aquestive Therapeutics Inc

Aquestive Therapeutics (AQST) Reports Q2 Loss, Tops Revenue Estimates - Aug 6th, 2019 6:05 pm
Aquestive Therapeutics Reports Second Quarter 2019 Financial Results and Recent Business Highlights - Aug 6th, 2019 3:22 pm
Aquestive Therapeutics Announces Positive Topline Results from Libervant™ (Diazepam) Buccal Film Single Dose Crossover Study - Aug 6th, 2019 2:28 pm
Will Aquestive Therapeutics (AQST) Report Negative Earnings Next Week? What You Should Know - Jul 31st, 2019 8:36 am
Aquestive Therapeutics to Present at 2019 Wedbush PacGrow Healthcare Conference - Jul 29th, 2019 9:45 am
Aquestive Therapeutics to Announce Second Quarter 2019 Financial Results and Recent Business Highlights on August 7, 2019 - Jul 18th, 2019 12:23 pm
What Percentage Of Aquestive Therapeutics, Inc. (NASDAQ:AQST) Shares Do Insiders Own? - Jul 17th, 2019 11:38 am
Aquestive Therapeutics Completes $70 Million Debt Refinancing - Jul 15th, 2019 2:35 pm
Aquestive Therapeutics to Present at Two Upcoming Investor Conferences - Jun 7th, 2019 6:30 am
Aquestive Therapeutics Completes Enrollment in Libervant™ (diazepam buccal film) Crossover Study - Jun 4th, 2019 6:00 am
Aquestive Therapeutics: 1Q Earnings Snapshot - May 8th, 2019 5:31 am
Aquestive Therapeutics Reports First Quarter 2019 Financial Results and Recent Business Highlights - May 8th, 2019 5:00 am
IntelGenx and Aquestive Therapeutics Enter Worldwide Collaboration Agreement for Tadalafil - May 8th, 2019 5:00 am
Aquestive Therapeutics Announces Daniel Barber Named to Chief Operating Officer - May 7th, 2019 5:00 pm
Need To Know: Aquestive Therapeutics, Inc. (NASDAQ:AQST) Insiders Have Been Buying Shares - Apr 26th, 2019 1:55 pm
Aquestive Therapeutics to Announce First Quarter 2019 Financial Results and Recent Business Highlights on May 8, 2019 - Apr 17th, 2019 3:17 pm
Aquestive Therapeutics Announces U.S. Food and Drug Administration (FDA) Acceptance of New Drug Application for Riluzole Oral Film for Treatment of ALS - Apr 16th, 2019 6:00 am
Aquestive Therapeutics to Present at H.C. Wainwright Global Life Sciences Conference - Mar 25th, 2019 2:25 pm
Aquestive Therapeutics (AQST) Upgraded to Buy: Here's Why - Mar 21st, 2019 7:00 am